HEADER OXIDOREDUCTASE 18-JUN-21 7F4C TITLE THE CRYSTAL STRUCTURE OF THE IMMATURE HOLO-ENZYME OF HOMOSERINE TITLE 2 DEHYDROGENASE COMPLEXED WITH NADP AND 1,4-BUTANDIOL FROM THE TITLE 3 HYPERTHERMOPHILIC ARCHAEON SULFURISPHAERA TOKODAII. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HOMOSERINE DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.1.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SULFURISPHAERA TOKODAII (STRAIN DSM 16993 / JCM SOURCE 3 10545 / NBRC 100140 / 7); SOURCE 4 ORGANISM_COMMON: SULFOLOBUS TOKODAII; SOURCE 5 ORGANISM_TAXID: 273063; SOURCE 6 STRAIN: DSM 16993 / JCM 10545 / NBRC 100140 / 7; SOURCE 7 GENE: HOM, ST1519, STK_15190; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET101 KEYWDS HEAT-INDUCED ACTIVATION, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR K.OGATA,R.KANEKO,T.KUBOTA,K.WATANABE,E.KURIHARA,T.OSHIMA,K.YOSHIMUNE, AUTHOR 2 M.GOTO REVDAT 3 29-NOV-23 7F4C 1 REMARK REVDAT 2 10-AUG-22 7F4C 1 JRNL REVDAT 1 22-JUN-22 7F4C 0 JRNL AUTH T.KUBOTA,E.KURIHARA,K.WATANABE,K.OGATA,R.KANEKO,M.GOTO, JRNL AUTH 2 T.OHSHIMA,K.YOSHIMUNE JRNL TITL CONFORMATIONAL CHANGES IN THE CATALYTIC REGION ARE JRNL TITL 2 RESPONSIBLE FOR HEAT-INDUCED ACTIVATION OF HYPERTHERMOPHILIC JRNL TITL 3 HOMOSERINE DEHYDROGENASE. JRNL REF COMMUN BIOL V. 5 704 2022 JRNL REFN ESSN 2399-3642 JRNL PMID 35835834 JRNL DOI 10.1038/S42003-022-03656-7 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.05 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 40077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2070 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2612 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4395 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 238 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : 0.05000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.194 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.257 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4577 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6219 ; 1.388 ; 2.014 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 582 ; 5.984 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;37.981 ;25.233 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 758 ;14.412 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;15.185 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 737 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3336 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7F4C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1300022843. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42219 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 63.196 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.28100 REMARK 200 R SYM FOR SHELL (I) : 0.28100 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5AVO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG2000, MAGNESIUM CHLORIDE, PEG400, REMARK 280 1,4-BUTANDIOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.52600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 228 REMARK 465 LYS A 229 REMARK 465 ASN A 230 REMARK 465 GLU A 231 REMARK 465 THR B 163 REMARK 465 LEU B 164 REMARK 465 MET B 165 REMARK 465 ASN B 166 REMARK 465 LYS B 167 REMARK 465 GLY B 168 REMARK 465 VAL B 169 REMARK 465 SER B 170 REMARK 465 ASN B 224 REMARK 465 ARG B 225 REMARK 465 ASP B 226 REMARK 465 LEU B 227 REMARK 465 PRO B 228 REMARK 465 LYS B 229 REMARK 465 ASN B 230 REMARK 465 GLU B 231 REMARK 465 LYS B 232 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 22 CG CD CE NZ REMARK 470 LYS A 46 CG CD CE NZ REMARK 470 GLU A 54 CG CD OE1 OE2 REMARK 470 GLU A 89 CG CD OE1 OE2 REMARK 470 ARG A 117 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 146 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 LYS A 176 CG CD CE NZ REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 GLU A 221 CG CD OE1 OE2 REMARK 470 ARG A 225 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 2 CG CD CE NZ REMARK 470 LYS B 22 CG CD CE NZ REMARK 470 ARG B 39 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 54 CG CD OE1 OE2 REMARK 470 GLU B 62 CG CD OE1 OE2 REMARK 470 ARG B 117 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 160 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 LYS B 176 CG CD CE NZ REMARK 470 GLU B 177 CG CD OE1 OE2 REMARK 470 ILE B 192 CG1 CG2 CD1 REMARK 470 ASN B 193 CG OD1 ND2 REMARK 470 LYS B 219 CG CD CE NZ REMARK 470 GLU B 221 CG CD OE1 OE2 REMARK 470 ILE B 223 CG1 CG2 CD1 REMARK 470 ILE B 233 CG1 CG2 CD1 REMARK 470 LYS B 247 CG CD CE NZ REMARK 470 GLN B 253 CG CD OE1 NE2 REMARK 470 ASP B 254 CG OD1 OD2 REMARK 470 TYR B 258 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 8 46.70 -149.49 REMARK 500 LEU A 43 36.65 -90.74 REMARK 500 ASN A 79 3.37 -155.38 REMARK 500 ALA A 108 38.89 -143.68 REMARK 500 PHE A 125 20.00 -146.28 REMARK 500 SER A 131 -105.68 49.87 REMARK 500 SER A 135 -72.70 -138.46 REMARK 500 LEU A 142 53.51 -119.84 REMARK 500 TYR B 8 47.71 -150.75 REMARK 500 LEU B 43 33.21 -82.93 REMARK 500 ASN B 79 2.08 -153.78 REMARK 500 ALA B 108 39.43 -145.81 REMARK 500 PHE B 125 23.44 -145.08 REMARK 500 SER B 131 -108.12 50.37 REMARK 500 SER B 135 -75.81 -136.39 REMARK 500 LEU B 142 53.15 -116.00 REMARK 500 SER B 212 83.51 -64.04 REMARK 500 GLU B 221 -123.65 -124.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 629 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH B 609 DISTANCE = 7.97 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7F4B RELATED DB: PDB REMARK 900 7F4B CONTAINS THE SAME PROTEIN IN APO FORM. DBREF 7F4C A 1 304 UNP F9VNG5 F9VNG5_SULTO 1 304 DBREF 7F4C B 1 304 UNP F9VNG5 F9VNG5_SULTO 1 304 SEQRES 1 A 304 MET LYS LEU LEU LEU PHE GLY TYR GLY ASN VAL GLY LYS SEQRES 2 A 304 ALA PHE ARG LYS LEU LEU HIS GLU LYS ARG SER PRO GLU SEQRES 3 A 304 LEU ASN ASP VAL ILE ILE GLY GLY ILE VAL THR ARG ARG SEQRES 4 A 304 GLY ILE MET LEU GLN ASP LYS GLU ASP PHE THR PRO ASP SEQRES 5 A 304 LEU GLU GLY ASP VAL PHE LYS ALA PHE GLU LYS ILE LYS SEQRES 6 A 304 PRO ASP ILE ILE VAL ASP VAL SER SER ALA ASN TYR ASN SEQRES 7 A 304 ASN GLY GLU PRO SER LEU SER LEU TYR LYS GLU ALA ILE SEQRES 8 A 304 LYS ASP GLY VAL ASN ILE ILE THR THR ASN LYS ALA PRO SEQRES 9 A 304 LEU ALA LEU ALA PHE ASN GLU ILE PHE SER LEU ALA ARG SEQRES 10 A 304 SER LYS GLY VAL LYS ILE GLY PHE GLN GLY THR VAL MET SEQRES 11 A 304 SER GLY THR PRO SER ILE ASN LEU TYR ARG VAL LEU PRO SEQRES 12 A 304 GLY SER ARG VAL ILE LYS ILE ARG GLY ILE LEU ASN GLY SEQRES 13 A 304 THR THR ASN PHE ILE LEU THR LEU MET ASN LYS GLY VAL SEQRES 14 A 304 SER PHE GLU GLU ALA LEU LYS GLU ALA GLN ARG ARG GLY SEQRES 15 A 304 TYR ALA GLU GLU ASP PRO THR LEU ASP ILE ASN GLY PHE SEQRES 16 A 304 ASP ALA ALA ALA LYS ILE THR ILE LEU ALA ASN PHE MET SEQRES 17 A 304 ILE GLY ASN SER VAL THR ILE LYS ASP VAL LYS PHE GLU SEQRES 18 A 304 GLY ILE ASN ARG ASP LEU PRO LYS ASN GLU LYS ILE LYS SEQRES 19 A 304 LEU ILE ALA TYR ALA ASP GLU LYS GLU VAL TRP VAL LYS SEQRES 20 A 304 PRO LEU PRO ILE SER GLN ASP ASP PRO LEU TYR ASN VAL SEQRES 21 A 304 ASP GLY VAL GLU ASN ALA LEU GLU ILE THR THR ASP ILE SEQRES 22 A 304 GLN SER ILE LEU ILE ARG GLY PRO GLY ALA GLY PRO VAL SEQRES 23 A 304 ASN ALA ALA TYR GLY ALA LEU SER ASP LEU ILE LEU LEU SEQRES 24 A 304 LYS ARG ASP CYS LEU SEQRES 1 B 304 MET LYS LEU LEU LEU PHE GLY TYR GLY ASN VAL GLY LYS SEQRES 2 B 304 ALA PHE ARG LYS LEU LEU HIS GLU LYS ARG SER PRO GLU SEQRES 3 B 304 LEU ASN ASP VAL ILE ILE GLY GLY ILE VAL THR ARG ARG SEQRES 4 B 304 GLY ILE MET LEU GLN ASP LYS GLU ASP PHE THR PRO ASP SEQRES 5 B 304 LEU GLU GLY ASP VAL PHE LYS ALA PHE GLU LYS ILE LYS SEQRES 6 B 304 PRO ASP ILE ILE VAL ASP VAL SER SER ALA ASN TYR ASN SEQRES 7 B 304 ASN GLY GLU PRO SER LEU SER LEU TYR LYS GLU ALA ILE SEQRES 8 B 304 LYS ASP GLY VAL ASN ILE ILE THR THR ASN LYS ALA PRO SEQRES 9 B 304 LEU ALA LEU ALA PHE ASN GLU ILE PHE SER LEU ALA ARG SEQRES 10 B 304 SER LYS GLY VAL LYS ILE GLY PHE GLN GLY THR VAL MET SEQRES 11 B 304 SER GLY THR PRO SER ILE ASN LEU TYR ARG VAL LEU PRO SEQRES 12 B 304 GLY SER ARG VAL ILE LYS ILE ARG GLY ILE LEU ASN GLY SEQRES 13 B 304 THR THR ASN PHE ILE LEU THR LEU MET ASN LYS GLY VAL SEQRES 14 B 304 SER PHE GLU GLU ALA LEU LYS GLU ALA GLN ARG ARG GLY SEQRES 15 B 304 TYR ALA GLU GLU ASP PRO THR LEU ASP ILE ASN GLY PHE SEQRES 16 B 304 ASP ALA ALA ALA LYS ILE THR ILE LEU ALA ASN PHE MET SEQRES 17 B 304 ILE GLY ASN SER VAL THR ILE LYS ASP VAL LYS PHE GLU SEQRES 18 B 304 GLY ILE ASN ARG ASP LEU PRO LYS ASN GLU LYS ILE LYS SEQRES 19 B 304 LEU ILE ALA TYR ALA ASP GLU LYS GLU VAL TRP VAL LYS SEQRES 20 B 304 PRO LEU PRO ILE SER GLN ASP ASP PRO LEU TYR ASN VAL SEQRES 21 B 304 ASP GLY VAL GLU ASN ALA LEU GLU ILE THR THR ASP ILE SEQRES 22 B 304 GLN SER ILE LEU ILE ARG GLY PRO GLY ALA GLY PRO VAL SEQRES 23 B 304 ASN ALA ALA TYR GLY ALA LEU SER ASP LEU ILE LEU LEU SEQRES 24 B 304 LYS ARG ASP CYS LEU HET NAP A 401 48 HET BU1 A 402 6 HET NAP B 401 48 HET BU1 B 402 6 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM BU1 1,4-BUTANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 BU1 2(C4 H10 O2) FORMUL 7 HOH *238(H2 O) HELIX 1 AA1 GLY A 9 GLU A 21 1 13 HELIX 2 AA2 SER A 24 ASN A 28 5 5 HELIX 3 AA3 ASP A 56 LYS A 65 1 10 HELIX 4 AA4 PRO A 82 ASP A 93 1 12 HELIX 5 AA5 LYS A 102 GLY A 120 1 19 HELIX 6 AA6 PHE A 125 VAL A 129 5 5 HELIX 7 AA7 SER A 135 VAL A 141 1 7 HELIX 8 AA8 ASN A 155 LYS A 167 1 13 HELIX 9 AA9 SER A 170 ARG A 181 1 12 HELIX 10 AB1 PRO A 188 ASN A 193 1 6 HELIX 11 AB2 GLY A 194 MET A 208 1 15 HELIX 12 AB3 THR A 214 VAL A 218 5 5 HELIX 13 AB4 GLY A 284 ARG A 301 1 18 HELIX 14 AB5 GLY B 9 GLU B 21 1 13 HELIX 15 AB6 SER B 24 ASN B 28 5 5 HELIX 16 AB7 ASP B 56 LYS B 65 1 10 HELIX 17 AB8 PRO B 82 ASP B 93 1 12 HELIX 18 AB9 LYS B 102 GLY B 120 1 19 HELIX 19 AC1 PHE B 125 VAL B 129 5 5 HELIX 20 AC2 SER B 135 VAL B 141 1 7 HELIX 21 AC3 ASN B 155 LEU B 162 1 8 HELIX 22 AC4 GLU B 172 ARG B 181 1 10 HELIX 23 AC5 PRO B 188 ASN B 193 1 6 HELIX 24 AC6 GLY B 194 ILE B 209 1 16 HELIX 25 AC7 THR B 214 VAL B 218 5 5 HELIX 26 AC8 GLY B 284 ARG B 301 1 18 SHEET 1 AA1 6 GLY A 40 MET A 42 0 SHEET 2 AA1 6 ILE A 31 THR A 37 -1 N ILE A 35 O MET A 42 SHEET 3 AA1 6 LYS A 2 PHE A 6 1 N LEU A 3 O ILE A 31 SHEET 4 AA1 6 ILE A 68 ASP A 71 1 O VAL A 70 N PHE A 6 SHEET 5 AA1 6 ASN A 96 THR A 99 1 O ILE A 98 N ASP A 71 SHEET 6 AA1 6 ILE A 123 GLY A 124 1 O GLY A 124 N ILE A 97 SHEET 1 AA212 LYS A 219 PHE A 220 0 SHEET 2 AA212 VAL A 244 PRO A 250 1 O VAL A 246 N LYS A 219 SHEET 3 AA212 ILE A 233 ASP A 240 -1 N LYS A 234 O LEU A 249 SHEET 4 AA212 VAL A 147 ILE A 153 -1 N GLY A 152 O ALA A 237 SHEET 5 AA212 GLU A 264 THR A 271 -1 O GLU A 268 N ARG A 151 SHEET 6 AA212 SER A 275 PRO A 281 -1 O GLY A 280 N ASN A 265 SHEET 7 AA212 SER B 275 PRO B 281 -1 O ARG B 279 N LEU A 277 SHEET 8 AA212 GLU B 264 THR B 271 -1 N ASN B 265 O GLY B 280 SHEET 9 AA212 VAL B 147 ILE B 153 -1 N ARG B 151 O GLU B 268 SHEET 10 AA212 LYS B 234 ASP B 240 -1 O ALA B 237 N GLY B 152 SHEET 11 AA212 VAL B 244 LEU B 249 -1 O TRP B 245 N TYR B 238 SHEET 12 AA212 LYS B 219 PHE B 220 1 N LYS B 219 O VAL B 246 SHEET 1 AA3 6 GLY B 40 MET B 42 0 SHEET 2 AA3 6 ILE B 31 THR B 37 -1 N ILE B 35 O MET B 42 SHEET 3 AA3 6 LYS B 2 PHE B 6 1 N LEU B 5 O GLY B 34 SHEET 4 AA3 6 ILE B 68 ASP B 71 1 O VAL B 70 N LEU B 4 SHEET 5 AA3 6 ASN B 96 THR B 99 1 O ILE B 98 N ASP B 71 SHEET 6 AA3 6 ILE B 123 GLY B 124 1 O GLY B 124 N ILE B 97 SSBOND 1 CYS A 303 CYS B 303 1555 1555 2.05 CISPEP 1 GLU A 81 PRO A 82 0 4.91 CISPEP 2 GLU B 81 PRO B 82 0 1.63 CRYST1 55.328 79.052 65.914 90.00 106.51 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018074 0.000000 0.005358 0.00000 SCALE2 0.000000 0.012650 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015824 0.00000